scholarly article | Q13442814 |
P356 | DOI | 10.1097/00001721-200304000-00010 |
P698 | PubMed publication ID | 12695752 |
P50 | author | James S O'Donnell | Q43228933 |
P2093 | author name string | Paul O'Brien | |
Karen Murphy | |||
Chrissann Fleming | |||
Sandra Doyle | |||
P433 | issue | 3 | |
P304 | page(s) | 283-287 | |
P577 | publication date | 2003-04-01 | |
P1433 | published in | Blood Coagulation and Fibrinolysis | Q15752432 |
P1476 | title | Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. | |
P478 | volume | 14 |
Q37776318 | A comparison of methods of pathogen inactivation of FFP |
Q60034604 | Acquired protein s deficiency in thrombotic thrombocytopenic purpura patients receiving solvent/detergent plasma exchange |
Q33873316 | Clinical review: Fresh frozen plasma in massive bleedings - more questions than answers |
Q33368173 | Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A light |
Q33360121 | Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura |
Q53271141 | Fresh frozen plasma is ineffective for correcting minimally elevated international normalized ratios. |
Q26741073 | Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use |
Q33361279 | Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials |
Q43198171 | Plasma, guidelines, and evidence-based medicine. |
Q37209117 | Recommendations for the transfusion of plasma and platelets |
Q37062415 | Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma |
Q45885033 | Severe factor V deficiency and pregnancy - a role for solvent-detergent plasma? |
Q38213153 | Solvent/detergent plasma: pharmaceutical characteristics and clinical experience |
Q33244111 | Splenectomy and proximal lieno-renal shunt in a factor five deficient patient with extra-hepatic portal vein obstruction |
Q36874269 | Virus-inactivated plasma - Plasmasafe: a one-year experience |
Search more.